Stock_Titan Posted - 2 days ago

$HYPR Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study https://www.stocktitan.net/news/HYPR/leading-institutions-enroll-first-alzheimer-s-patients-receiving-v6hu1i0e1xx7.html

SusQSmallMouth Posted - 1 week ago

$HYPR any idea why they only guided 12 to 15 million for 2024? You would think 15 would be the low end. I'm tempted to get back in this. Traded it before from around $1 to $2.30 last year. Was any of their 11 million revenue in 2023 one time occurrences? Cash runway into 2026 and trading below cash as of 12/31/2023. - $75M. One nice news drop could pop this. But why Rev guidence so slow? This is the only risk at the moment I see.

alchemy2442 Posted - 1 week ago

$HYPR Really quite here…

JoatNH Posted - 03/22/24

$HYPR They should license their AI Imaging technology for extra revenue...

SchwallerCapital Posted - 03/22/24

$HYPR a gift here as well

JoatNH Posted - 03/22/24

$HYPR 1.25M shares short, will they squeeze to get back in at higher prices?

mikesterz7 Posted - 03/21/24

$HYPR Hyperfine press release (NASDAQ:HYPR): Q4 GAAP EPS of -$0.15 beats by $0.03. Revenue of $2.69M (+89.4% Y/Y) misses by $1.02M.

JoatNH Posted - 03/21/24

$HYPR As their technology continues mature and be proven and accepted they will be bought before they run out of cash IMO. Cheaper to buy the tech then spend time and money developing.

DonCorleone77 Posted - 03/21/24

$HYPR Hyperfine sees FY24 revenue $12M-$15M, consensus $18.35M The company said, "Management expects revenue for the full year 2024 to be $12 to $15 million. Management expects revenue for the first quarter 2024 to be over $3 million. Management expects cash burn for the full year 2024 to be approximately $40 million."

DonCorleone77 Posted - 03/21/24

$HYPR Hyperfine reports Q4 EPS (15c), consensus (18c) Reports Q4 revenue $2.69M, consensus $3.71M. "I am pleased with our strong growth in 2023. We continued to drive adoption in our beachhead markets of critical care and pediatrics, and we made significant progress to expand our use cases through clinical evidence and innovation," said Maria Sainz, CEO and president of Hyperfine, Inc. "We remain focused on our 3 strategic pillars in 2024; our technology has been highlighted at several medical conferences, we are selling systems into new flagship institutions, and we have mobilized to build a robust program supporting Swoop's utility in Alzheimer's disease."

Stock_Titan Posted - 03/21/24

$HYPR Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/HYPR/hyperfine-inc-reports-fourth-quarter-and-full-year-2023-financial-6yprp50bs7tk.html

SchwallerCapital Posted - 03/21/24

$HYPR Trade Idea: Shares into earnings, think this one is good for a double with patience.

JoatNH Posted - 03/20/24

$HYPR Should be interesting to see # of units in the first qtr. IMO with the new software upgrade with real time data processing that Radiologists will start to look more at this tech. The knock has been image clarity and maybe their first impression is based on the preprocessed images. Having them in real time will allow for making calls quicker and possibly rescan a targeted area.

FROGGER111 Posted - 1 month ago

$HYPR great product just hard to get legs in that sector with the control of competition

Dubds Posted - 1 month ago

$HYPR interesting

Stock_Titan Posted - 1 month ago

$HYPR Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal https://www.stocktitan.net/news/HYPR/hyperfine-inc-collaborates-with-king-s-college-london-to-demonstrate-ye2tag97per7.html

Stock_Titan Posted - 1 month ago

$HYPR Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 https://www.stocktitan.net/news/HYPR/hyperfine-inc-to-announce-fourth-quarter-and-full-year-2023-qozgt3rnmnem.html

Dubds Posted - 1 month ago

$HYPR weekly view. While I don't see any recent accumulation, there has been significant buying in the past. Whats interesting is those who accumulated are still holding based on volume. A close above the 5 weekly EMA will establish momentum including break of the downtrend.

StockMET Posted - 1 month ago

$HYPR nice entry from here 📈

JoatNH Posted - 02/29/24

$HYPR Interesting day today... 1.2M short and 35 days to cover. 3 weeks to earnings... https://fintel.io/ss/us/hypr

Stock_Titan Posted - 02/28/24

$HYPR Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference https://www.stocktitan.net/news/HYPR/hyperfine-inc-to-present-at-the-oppenheimer-34th-annual-healthcare-mcjxou4sh9g8.html

Stock_Titan Posted - 02/21/24

$HYPR Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes https://www.stocktitan.net/news/HYPR/hyperfine-inc-announces-collaboration-with-athletic-heart-to-provide-y6w6j3yrtarx.html

QuantArb1 Posted - 2 months ago

$HYPR with $NNOX flying today on the back of $NVDA I can only imagine, that $HYPR Is better positioned given Its more mature, has more sophisticated tech and real AI...

Hagler Posted - 2 months ago

$BFLY can't depend on this solo product to save us. The inventor has other products that he decided to go solo with each product instead of consolidation to form a great brand. He has $QSI and $HYPR and they are all doing not so good.

JoatNH Posted - 2 months ago

$HYPR Looks like they will be presenting data Wed & Thursday evenings. Wed evening presentation should be interesting based on the ongoing Mass General studies.

desi_girl_03 Posted - 01/31/24

$HYPR when are the earnings?

tudu Posted - 01/30/24

$NVVE will go back to 5.80 again later today :-) WL also $NEXI $HYPR

cheating_stock_investor Posted - 3 months ago

$AFIB damn now the chair is jumping ship im not surprised if the next step is for them to delist the company then fleece remaining shareholders to fight for rights on a non existent sec reporting co They basically spent the last 60 days cya gave any legitimate investor the chance to dump shares. With the chair who was accountable for keeping the board together and fiduciary for shareholders gone, no doubt this company is now like a chicken with its head cut off. Expensive lesson i learned here is never invest in a company with a chairman that is part of 20 different small companies where their interest is to hope one day one of them do something big and put that on his resume while leaving the other 19 failures off the list. The next one following the path of afib is $HYPR

JoatNH Posted - 3 months ago

$HYPR Looks like the software update is key to acceptance of this system, not from just a quality stand point, but now the scans are virtually real time. I could see hesitation if you have to wait for the image, now decisions can be made faster. Still believe one day a prime MRI will purchase HYPR either to bury the tech or augment theirs. JMO

tickeron Posted - 3 months ago

Good move or bad move? $HYPR Aroon Indicator entered a Downtrend. View odds of downtrend. https://srnk.us/go/4968635